Attention deficit hyperactivity disorder and Dupuytren's contracture
Dupuytren's contracture is reported only by a few people with Attention deficit hyperactivity disorder.
The study analyzes which people have Dupuytren's contracture with Attention deficit hyperactivity disorder. It is created by eHealthMe based on 2 people who have Dupuytren's contracture and Attention deficit hyperactivity disorder from the Food and Drug Administration (FDA), and is updated regularly.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
2 people who have Attention Deficit Hyperactivity Disorder and Dupuytren'S Contracture are studied.
What is Attention deficit hyperactivity disorder?
Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness) is found to be associated with 1,402 drugs and 1,122 conditions by eHealthMe.
What is Dupuytren's contracture?
Dupuytren's contracture (thickening of the fibrous tissue layer underneath the skin of the palm and fingers) is found to be associated with 434 drugs and 193 conditions by eHealthMe.
Number of Dupuytren's contracture in Attention deficit hyperactivity disorder reports submitted per year:
Gender of people who have Attention Deficit Hyperactivity Disorder and experienced Dupuytren'S Contracture *:
- female: 0.0 %
- male: 100 %
Age of people who have Attention Deficit Hyperactivity Disorder and experienced Dupuytren'S Contracture *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 50 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 50 %
Common drugs taken by these people *:
- Strattera: 1 person, 50.00%
- Metoprolol Succinate: 1 person, 50.00%
- Gemfibrozil: 1 person, 50.00%
- Gabapentin: 1 person, 50.00%
- Concerta: 1 person, 50.00%
Common symptoms for these people *:
- Weight Increased: 1 person, 50.00%
- Gait Disturbance: 1 person, 50.00%
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 50.00%
- Diplopia (double vision): 1 person, 50.00%
- Dizziness Postural: 1 person, 50.00%
- Dry Mouth: 1 person, 50.00%
- Eating Disorder: 1 person, 50.00%
- Eye Irritation: 1 person, 50.00%
- Eye Pruritus (eye itching): 1 person, 50.00%
- Fall: 1 person, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Dupuytren's contracture?Check whether Dupuytren's contracture is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
Treatments, associated drugs and conditions:
COVID vaccines that are related to Dupuytren's contracture:
- Dupuytren's contracture in Moderna COVID Vaccine
- Dupuytren's contracture in Pfizer BioNTech Covid Vaccine
- Dupuytren's contracture in Johnson and Johnson Covid Vaccine
Common drugs associated with Dupuytren's contracture:
- Xiaflex: 137 reports
All the drugs that are associated with Dupuytren's contracture:
- Dupuytren's contracture (434 drugs)
All the conditions that are associated with Dupuytren's contracture:
- Dupuytren's contracture (193 conditions)
How the study uses the data?
The study is based on Dupuytren's contracture and Attention deficit hyperactivity disorder, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Diltiazem Hydrochloride and Vaginal Bleeding - 46 seconds ago
- Avastin and Enterocutaneous Fistula - a minute ago
- Hair Growth Abnormal and Arrhythmias - a minute ago
- Cosopt and Atripla drug interaction - a minute ago
- How effective is Carvedilol for Blood Pressure Management? - a minute ago